首页> 美国卫生研究院文献>Clinical Molecular Pathology >Reactive and neoplastic lymphocytes in human bone marrow: morphological immunohistological and molecular biological investigations on biopsy specimens.
【2h】

Reactive and neoplastic lymphocytes in human bone marrow: morphological immunohistological and molecular biological investigations on biopsy specimens.

机译:人类骨髓中的反应性和肿瘤性淋巴细胞:活检标本的形态免疫组织学和分子生物学研究。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BACKGROUND: Slight, diffuse or focal lymphocyte proliferation is relatively common in bone marrow biopsy specimens. It may be impossible to determine whether this represents a reactive lymphocytosis or low grade non-Hodgkin lymphoma (NHL) on the basis of routine investigations alone. AIM: To investigate the supplementary use of molecular biological techniques in this situation. METHODS: 529 formalin fixed, paraffin embedded bone marrow biopsy specimens from the iliac crest were subjected to histological and immunohistochemical staining to determine the number and nature of the lymphocytes present. The cases were divided into three groups according to the lymphocyte count: normal (< 10% of nucleated bone marrow cells), slightly increased (10-30%), and markedly increased (> 30%). All of the last group could be diagnosed as NHL from the morphological findings alone. The clonality of rearrangements of the IgH and TCR gamma genes was investigated by polymerase chain reaction (PCR). RESULTS: Monoclonality was observed in 7.5% of the 372 cases with a normal lymphocyte count, in 50% of the cases with a modest increase in lymphocyte numbers (suggesting a diagnosis of low grade NHL not detected by immunostaining), and in 77% of the cases with markedly increased lymphocyte numbers. CONCLUSIONS: If PCR is used in addition to the immunohistochemical investigation of bone marrow biopsies, considerably more cases of NHL can be identified, making this of particular use in staging and detection of recurrences.
机译:背景:轻度,弥漫性或局灶性淋巴细胞增殖在骨髓活检标本中相对普遍。仅凭常规检查就可能无法确定这是反应性淋巴细胞增多还是低度非霍奇金淋巴瘤(NHL)。目的:研究在这种情况下分子生物学技术的补充使用。方法:对529只福尔马林固定的,来自the的石蜡包埋的骨髓活检标本进行组织学和免疫组织化学染色,以确定存在的淋巴细胞的数量和性质。根据淋巴细胞计数将病例分为三组:正常(有核骨髓细胞的<10%),略有增加(10-30%)和显着增加(> 30%)。仅从形态学发现就可以将最后一组全部诊断为NHL。通过聚合酶链反应(PCR)研究了IgH和TCRγ基​​因重排的克隆性。结果:在372例淋巴细胞计数正常的病例中,有7.5%观察到了单克隆性,在淋巴细胞数量适度增加的病例中观察到了50%的病例(建议通过免疫染色未发现低级NHL的诊断),而在77%的患者中淋巴细胞数量明显增加的病例。结论:如果在骨髓活检的免疫组织化学研究之外还使用PCR,则可以鉴定出更多的NHL病例,这在分期和复发检测中特别有用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号